glp 1 in non diabetic Only a few week old (2026 jan 22) systematic review revealed that GLP-1 agonists have the greatest benefit for younger non-diabetic female patients. https://diabetesjournals.org/care/article/48/2/292/157724/Efficacy-of-GLP-1-Receptor-Agonists-on-Weight The GLP-1 Agonists and Obesity:
Description
Endocrinology, 8
p = 0.025), whereas no reduction was observed in AST ( p = 0.075) or ALT ( p = 0.10)
Safety info: GLP-1 medications are used to treat obesity or overweight (with weight-related problems), along with diet and exercise
If symptoms continue beyond this timeframe, your doctor may recommend additional testing to assess stomach function
Experts to Give Update on GLP-1 RAs and SGLT2i as Adjuncts to Automated Insulin Delivery
